Renaissance Technologies’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Sell |
1,234,100
-44,300
| -3% | -$159K | 0.01% | 1593 |
|
|
2025
Q1 | $3.82M | Buy |
1,278,400
+61,800
| +5% | +$185K | 0.01% | 1589 |
|
|
2024
Q4 | $4.08M | Buy |
1,216,600
+9,500
| +0.8% | +$31.8K | 0.01% | 1581 |
|
|
2024
Q3 | $4.04M | Buy |
1,207,100
+65,600
| +6% | +$220K | 0.01% | 1579 |
|
|
2024
Q2 | $3.78M | Buy |
1,141,500
+18,100
| +2% | +$59.9K | 0.01% | 1482 |
|
|
2024
Q1 | $4.54M | Sell |
1,123,400
-372,903
| -25% | -$1.51M | 0.01% | 1479 |
|
|
2023
Q4 | $4.56M | Buy |
1,496,303
+141,762
| +10% | +$432K | 0.01% | 1407 |
|
|
2023
Q3 | $4.06M | Sell |
1,354,541
-8,841
| -0.6% | -$26.5K | 0.01% | 1423 |
|
|
2023
Q2 | $5.1M | Buy |
1,363,382
+635,682
| +87% | +$2.38M | 0.01% | 1421 |
|
|
2023
Q1 | $2.44M | Buy |
727,700
+107,100
| +17% | +$359K | ﹤0.01% | 1902 |
|
|
2022
Q4 | $2.99M | Buy |
620,600
+23,200
| +4% | +$112K | ﹤0.01% | 1821 |
|
|
2022
Q3 | $3.4M | Sell |
597,400
-65,600
| -10% | -$373K | ﹤0.01% | 1683 |
|
|
2022
Q2 | $4.71M | Sell |
663,000
-502,000
| -43% | -$3.56M | 0.01% | 1610 |
|
|
2022
Q1 | $8.41M | Buy |
1,165,000
+544,200
| +88% | +$3.93M | 0.01% | 1232 |
|
|
2021
Q4 | $5.55M | Buy |
620,800
+598,200
| +2,647% | +$5.35M | 0.01% | 1466 |
|
|
2021
Q3 | $792K | Buy |
+22,600
| New | +$792K | ﹤0.01% | 2674 |
|